Y-90 therasphere, (ordering period i), tripler army medical center, HI

Ended Awarded Last action

Contract number
W81K0223F0006
Awardee
Awarding agency
Obligated
$19,000

Award facts

Opportunity
Contract value 100% obligated
$19,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Marlborough, MA 01752, USA

Award details come from SAM.gov/FPDS.

About this award

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, received a delivery order award from the Defense Health Agency on November 3, 2022, for Y-90 TheraSphere radiation treatment devices to support Tripler Army Medical Center in Hawaii. This firm fixed-price delivery order, valued at $19,000, represents ordering period I under a broader procurement vehicle and carries an ultimate completion date of September 30, 2023. No small business set-aside was utilized for this award, allowing Boston Scientific to compete on an unrestricted basis. The contract reflects the Defense Health Agency's reliance on Boston Scientific as a critical supplier of specialized oncology equipment and radiopharmaceuticals for military healthcare facilities.

This delivery order derives from Boston Scientific's established single-award Blanket Purchase Agreement with the Defense Health Agency, valued at $750,000 with a ceiling and completion date of March 30, 2030. The blanket purchase agreement, awarded on March 31, 2025, designates Boston Scientific as the sole supplier of radiation treatment devices, enabling the agency to issue multiple delivery orders for Y-90 glass microspheres and related radiation treatment technologies across military and Veterans Affairs medical centers. The underlying BPA structure streamlines procurement of complex specialized medical devices while ensuring supply chain continuity for critical cancer treatment modalities within the defense and veterans healthcare enterprises.

Quick answers

Who was awarded contract W81K0223F0006?

W81K0223F0006 was awarded to Boston Scientific Corp by Medical Command (Department of the Army) on November 3, 2022.

How much is contract W81K0223F0006 worth?

The government has obligated $19,000 on W81K0223F0006.

Which agency awarded contract W81K0223F0006?

Medical Command (Department of the Army) awarded W81K0223F0006, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0223F0006 an order under another contract?

Yes. W81K0223F0006 is a delivery order under W81K0222D0006, an indefinite delivery contract.

Was contract W81K0223F0006 competed?

The extent of competition for W81K0223F0006 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award